›› 2011, Vol. 31 ›› Issue (3): 373-.doi: 10.3969/j.issn.1674-8115.2011.03.030

• Review • Previous Articles     Next Articles

Research progress of molecular diagnostics of lung cancer

XUE Jian, LOU Jia-tao   

  1. Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China
  • Online:2011-03-28 Published:2011-03-29
  • Supported by:

    Shanghai Science and Technology Committee Foundation, 09441900702

PDF (PC)

3315

Abstract:

As a complement to imaging and cytology-based screening strategies, molecular diagnostics of lung cancer include not only the early detection but also the prognosis index and prediction of target therapy. In this paper, gene mutation, prediction of target therapy, miRNA, cancer stem cells and methylation in molecular diagnostics of lung cancer are reviewed.

Key words: gene mutation, target therapy, miRNA, cancer stem cell, methylation